3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
43
Colorectal Neoplasms
15
Squamous Cell Carcinoma of Head and Neck
13
Lung Neoplasms
13
Carcinoma, Non-Small-Cell Lung
13
Melanoma
12
Head and Neck Neoplasms
12
Pancreatic Neoplasms
11
Colonic Neoplasms
11
Carcinoma, Renal Cell
11
Rectal Neoplasms
10
Prostatic Neoplasms
9
Carcinoma, Ovarian Epithelial
8
Ovarian Neoplasms
7
Esophageal Neoplasms
7
Breast Neoplasms, Male
7
Salivary Gland Neoplasms
6
Lymphoma, Follicular
6
Lymphoma, B-Cell, Marginal Zone
6
Liver Neoplasms
6
Stomach Neoplasms
5
Precancerous Conditions
5
Lymphoma, Mantle-Cell
5
Lymphoma, Large-Cell, Anaplastic
5
Lymphoma, Large B-Cell, Diffuse
5
Kidney Neoplasms
5
Esophageal Squamous Cell Carcinoma
5
Breast Carcinoma In Situ
5
Adenocarcinoma Of Esophagus
5
Uterine Cervical Neoplasms
4
Interventions
Carboplatin
5
pembrolizumab
4
Trastuzumab
4
Oxaliplatin
4
Fluorouracil
4
Cyclophosphamide
4
Radiotherapy
3
Paclitaxel
3
Endoscopy
3
Docetaxel
3
Cytarabine
3
Chemoradiotherapy
3
Capecitabine
3
toripalimab
2
Tretinoin
2
Surgical Procedures, Operative
2
Standard of Care
2
Observation
2
Neoadjuvant Therapy
2
Metformin
2
Magnetic Resonance Imaging
2
Leucovorin
2
Irinotecan
2
Immunotherapy
2
Immune Checkpoint Inhibitors
2
Epirubicin
2
Drug Therapy
2
Doxorubicin
2
Cisplatin
2
Blood Specimen Collection
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Pathologic Complete Response
×
Immunohistochemistry
×
Clear all
NCT04917263
2021-06-08
IMMUNOREACT2
University of Padova
Unknown
544 enrolled